Reduced-dose radiation effective in HPV-associated oropharynx cancers

Induction chemotherapy followed by reduced-dose radiation and weekly cetuximab demonstrated improved swallowing and nutritional status as well as an excellent complete clinical response for patients with HPV-associated oropharyngeal squamous cell carcinoma, according to the results of a phase II study published in the Journal of Clinical Oncology.